Discovery of Taurocholic Acid Sodium Hydrate as a Novel Repurposing Drug for Intervertebral Disc Degeneration by Targeting MAPK3

MLA

Ping Li, et al. “Discovery of Taurocholic Acid Sodium Hydrate as a Novel Repurposing Drug for Intervertebral Disc Degeneration by Targeting MAPK3.” Orthopaedic Surgery, vol. 16, no. 1, Jan. 2024, pp. 183–95. EBSCOhost, https://doi.org/10.1111/os.13909.

APA

Ping Li, Zesen Chen, Keyu Meng, Yanlin Chen, Jiajia Xu, Xin Xiang, Xiuhua Wu, Zhiping Huang, Ruijun Lai, Peng Li, Zhongming Lai, Xiang Ao, Zhongyuan Liu, Kaifan Yang, Xiaochun Bai, & Zhongmin Zhang. (2024). Discovery of Taurocholic Acid Sodium Hydrate as a Novel Repurposing Drug for Intervertebral Disc Degeneration by Targeting MAPK3. Orthopaedic Surgery, 16(1), 183–195. https://doi.org/10.1111/os.13909

Chicago

Ping Li, Zesen Chen, Keyu Meng, Yanlin Chen, Jiajia Xu, Xin Xiang, Xiuhua Wu, et al. 2024. “Discovery of Taurocholic Acid Sodium Hydrate as a Novel Repurposing Drug for Intervertebral Disc Degeneration by Targeting MAPK3.” Orthopaedic Surgery 16 (1): 183–95. doi:10.1111/os.13909.